Inventor
VON LANGEN DEREK
US12 patents
Patents
12 patentsUS5910497AJun 8, 1999
16-pyrazinyl-substituted-4-aza-androstane 5-α-reductase isozyme 1 inhibitors
MERCK & CO INC18 citations92
US5719158AFeb 17, 1998
16-substituted-4-aza-androstane 5-alpha-reductase isozyme 1 inhibitors
MERCK & CO INC22 citations92
US5516779AMay 14, 1996
17β-substituted-6-azasteroid derivatives useful as 5α-reductase inhibitors
MERCK & CO INC35 citations92
US6090836AJul 18, 2000
Benzisoxazole-derived antidiabetic compounds
MERCK & CO INC24 citations91
US6160000ADec 12, 2000
Antidiabetic agents based on aryl and heteroarylacetic acids
MERCK & CO INC26 citations89
US5739137AApr 14, 1998
16-substituted-4-aza-3-oxo-androstane as 5-alpha-reductase isozyme 1 inhibitors
MERCK & CO INC14 citations82
US5438061AAug 1, 1995
7-substituted-δ4-6-azasteroid derivatives as 5α-reductase inhibitors
MERCK & CO INC9 citations73
US6048869AApr 11, 2000
Tricyclic compounds
MERCK & CO INC3 citations62
US6515015B1Feb 4, 2003
Antidiabetic agents based on aryl and heteroarylacetic acids
MERCK & CO INC3 citations59
US6204273B1Mar 20, 2001
16-substituted-4-aza-androstane 5-α-reductase isozyme 1 inhibitors
MERCK & CO INC0 citations52
US7622449B2Nov 24, 2009
Anti-hypercholesterolemic compounds
MERCK & CO INC1 citations51
US5663175ASep 2, 1997
Prodrugs of herpes TK inhibitors
MERCK & CO INC0 citations50